Related references
Note: Only part of the references are listed.Tissue modulus calculated from beam theory is biased by bone size and geometry:: Implications for the use of three-point bending tests to determine bone tissue modulus
G. Harry van Lenthe et al.
BONE (2008)
Activin in the Brain Modulates Anxiety-Related Behavior and Adult Neurogenesis
Hiroshi Ageta et al.
PLOS ONE (2008)
Bone morphogenetic protein
Yong-Tao Xiao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
The activin A-follistatin system: potent regulator of human extracellular matrix mineralization
Marco Eijken et al.
FASEB JOURNAL (2007)
Inhibin A is an endocrine stimulator of bone mass and strength
Daniel S. Perrien et al.
ENDOCRINOLOGY (2007)
VEGF, FGF1, FGF2 and EGF gene polymorphisms and psoriatic arthritis
Christopher Butt et al.
BMC MUSCULOSKELETAL DISORDERS (2007)
The role of TGFβs and Sox9 during limb chondrogenesis
Yasuhiko Kawakami et al.
CURRENT OPINION IN CELL BIOLOGY (2006)
Dissociation of angiogenesis and tumorigenesis in follistatin- and activin-expressing tumors
Jelena Krneta et al.
CANCER RESEARCH (2006)
Bone turnover across the menopause transition: Correlations with inhibins and follicle-stimulating hormone
DS Perrien et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Activin A circulating levels in patients with bone metastasis from breast or prostate cancer
Gaetano Leto et al.
CLINICAL & EXPERIMENTAL METASTASIS (2006)
The structure of the Follistatin:Activin complex reveals antagonism of both type I and type II receptor binding
TB Thompson et al.
DEVELOPMENTAL CELL (2005)
Regulation of activin mRNA and Smad2 phosphorylation by antidepressant treatment in the rat brain: Effects in behavioral models
AL Dow et al.
JOURNAL OF NEUROSCIENCE (2005)
BMP signaling in skeletal development
W Mei et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Antagonists of activin signaling: mechanisms and potential biological applications
CA Harrison et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2005)
Differential gene expression and regulation of the bone morphogenetic protein antagonists follistatin and gremlin in normal and osteoarthritic
G Tardif et al.
ARTHRITIS AND RHEUMATISM (2004)
Regulation of ovarian function by the TGF-β superfamily and follistatin
SY Lin et al.
REPRODUCTION (2003)
A multigenic program mediating breast cancer metastasis to bone
YB Kang et al.
CANCER CELL (2003)
Rat anterior pituitary folliculostellate cells are targets of interleukin-1β and a major source of intrapituitary follistatin
LM Bilezikjian et al.
ENDOCRINOLOGY (2003)
Expression of activin/inhibin receptor and binding protein genes and regulation of activin/inhibin peptide secretion in human adrenocortical cells
T Vänttinen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Follistatin regulates bone morphogenetic protein-7 (BMP-7) activity to stimulate embryonic muscle growth
H Amthor et al.
DEVELOPMENTAL BIOLOGY (2002)
Impaired wound healing in transgenic mice overexpressing the activin antagonist follistatin in the epidermis
M Wankell et al.
EMBO JOURNAL (2001)
The contribution of inhibins and activins to malignant prostate disease
GP Risbridger et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2001)
Involvement of activin in the regulation of bone metabolism
R Sakai et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2001)
Activin A is an essential cofactor for osteoclast induction
K Fuller et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Share Paper
